Polpharma Santo’s Plant Expansion
Turkistan Region, Kazakhstan
Project phase
Stage 2 of 4
- Initiation & Feasibility
- Engineering Design & PlanningCurrent
- Procurement & Construction
- Commissioning & Operation
Overview
About this project
The project involves the expansion of the existing Polpharma Santo (JSC “Khimpharm”) pharmaceutical production facility in Shymkent, Republic of Kazakhstan, with the construction of new manufacturing buildings and laboratory spaces.
Open this project free
A free account opens three complete project records — companies, named decision-makers, direct phone and email. No card, no trial period. See the real data before you decide whether it is worth paying for.
- The rest of the descriptionCapacity, technology, financing, current status and what happens next.
- Investment value and timelineAnnounced value, start and completion dates, status and last verification.
- Every involved companyOwner, investor, engineering and EPC contractors, operator, government bodies.
- Named decision-makersWho to speak to, with direct phone, email and LinkedIn.
- Verified sourcesThe primary sources behind each fact, so you can check it yourself.
Already have an account? Sign in to use your free unlocks.
Related
Other projects in Healthcare & Pharmaceuticals
Healthcare & PharmaceuticalsFull record lockedKokshetau Multidisciplinary Hospital (Updated)
Akmola
The Kokshetau Multidisciplinary Hospital is a large-scale public-private partnership (PPP) healthcare infrastructure project located in Kokshetau, Kazakhstan. The project involves the construction of a modern 630-bed hospital designed to serve over 730,000 residents of the Akmola region. It is being developed as a greenfield facility with a total built-up area of approximately 110,000–111,000 m² on a 17-hectare site.
Healthcare & PharmaceuticalsFull record lockedALEM – Medical Equipment Manufacturing Plant
Astana
The ALEM project aims to build a medical equipment manufacturing plant in Astana, Kazakhstan. The facility will produce innovative equipment for organ preservation and transportation, specifically for transplantation. The flagship product is a system that can keep donor organs viable for over 24 hours, which is a significant improvement over current methods that preserve organs for only 4-6 hours.
Healthcare & PharmaceuticalsFull record lockedMSN Pharmalab Pharmaceutical Manufacturing Plant
Almaty
The Indian pharmaceutical company MSN Group is partnering with Kazakhstan’s KFK Medservice Plus LLPto establish a full-cycle pharmaceutical manufacturing facility in the Almaty Region of Kazakhstan. The project involves the construction of a modern plant under the brand MSN Pharmalab, focusing on the production of solid dosage forms, including tablets and capsules.